Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of ocular topic antiinflammatory
therapy (sodic nepafenac at 0.1% or ketorolac at 0.5%) to treat center point thickness
secondary to selective photocoagulation in diabetics with clinically significant macular
edema.